BeOne Medicines (ONC) Deferred Taxes (2017 - 2023)
BeOne Medicines' (ONC) quarterly Deferred Taxes came in at -$46000.0 in Q4 2023, down 102.74% year-on-year from $1.7 million in Q4 2022, and down 106.13% on a QoQ basis from $750000.0 in Q3 2023.
BeOne Medicines (ONC) Deferred Taxes (2017 - 2023) Analysis & Trends
BeOne Medicines (ONC) has 7 years of Deferred Taxes data on file, last reported at -$46000.0 in Q4 2023.
- On a quarterly basis, Deferred Taxes fell 102.74% year-over-year to -$46000.0 in Q4 2023; TTM through Dec 2023 was $689000.0, a 66.54% decrease from a year earlier, with the FY2025 full-year figure at $9.5 million, down 63.56% from the prior year.
- Deferred Taxes for Q4 2023 stood at -$46000.0, down from $750000.0 in the prior quarter.
- Over the last five years, Deferred Taxes for ONC reached as high as $14.8 million in Q3 2021 and fell as low as -$12.3 million in Q1 2021.
- Historically, Deferred Taxes has averaged -$142300.0 across 5 years, with a median of -$48500.0 in 2023.
- Across the five-year window, Deferred Taxes tumbled 5847.09% in 2021 and surged 941.67% in 2022, its largest moves.
- Year by year, Deferred Taxes stood at $4.1 million in 2019, then surged by 119.97% to $9.0 million in 2020, then tumbled by 89.99% to $903000.0 in 2021, then surged by 85.94% to $1.7 million in 2022, then tumbled by 102.74% to -$46000.0 in 2023.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$46000.0 in Q4 2023, $750000.0 in Q3 2023, and -$51000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -46,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Jun 30, 2023 | -51,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | -175,000.00 |
| Jun 30, 2022 | 505,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 903,000.00 |
| Sep 30, 2021 | 14.79 Mn |
| Jun 30, 2021 | -60,000.00 |
| Mar 31, 2021 | -12.25 Mn |
| Dec 31, 2020 | 9.02 Mn |
| Sep 30, 2020 | -7.70 Mn |
| Jun 30, 2020 | -854,000.00 |
| Mar 31, 2020 | -206,000.00 |
| Dec 31, 2019 | 4.10 Mn |
| Sep 30, 2019 | -11.88 Mn |
| Jun 30, 2019 | -473,000.00 |
| Mar 31, 2019 | -983,000.00 |